Publicaciones en colaboración con investigadores/as de Universidad de Valladolid (36)

2024

  1. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

    Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

    Journal of Bone and Mineral Research

  3. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 2, pp. 88-93

  2. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

    Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978

  3. Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e22

  4. Impact of depression and anxiety on dimensions of health-related quality of life in subjects with parkinson’s disease enrolled in an association of patients

    Brain Sciences, Vol. 11, Núm. 6

2020

  1. Comparison of knowledge, attitudes and hand hygiene behavioral intention in medical and nursing students

    Journal of preventive medicine and hygiene, Vol. 61, Núm. 1, pp. E9-E14

  2. Prevalence of Depression and Anxiety in Parkinson Disease and Impact on Quality of Life: A Community-Based Study in Spain

    Journal of Geriatric Psychiatry and Neurology, Vol. 33, Núm. 4, pp. 207-213

2019

  1. Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: A Meta-analysis of Observational Studies

    Journal of Clinical Pharmacology, Vol. 59, Núm. 1, pp. 55-73

  2. Gastrointestinal safety of coxibs: systematic review and meta-analysis of observational studies on selective inhibitors of cyclo-oxygenase 2

    Fundamental and Clinical Pharmacology, Vol. 33, Núm. 2, pp. 134-147

  3. Medicines under additional monitoring in the European Union

    Farmacia Hospitalaria, Vol. 43, Núm. 1, pp. 19-23

  4. What can we learn from the public's understanding of drug information and safety? A population survey

    International Journal of Pharmacy Practice, Vol. 27, Núm. 1, pp. 96-104

2018

  1. A polypharmacy risk prediction model for elderly patients based on sociodemographic and clinical factors

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 56, Núm. 12, pp. 577-584

  2. Association between Frequency of Consumption of Fruit, Vegetables, Nuts and Pulses and BMI: Analyses of the International Study of Asthma and Allergies in Childhood (ISAAC)

    Nutrients, Vol. 10, Núm. 3

  3. Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study

    International Journal of Clinical Pharmacy, Vol. 40, Núm. 4, pp. 928-935

2017

  1. Medication errors associated with oral administration of methotrexate. Data from spontaneous reporting and medical literature review

    Medicina Clinica, Vol. 148, Núm. 7, pp. 330-332